These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. British Fertility Society. 'Ovulation induction in WHO Type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS Policy and Practice Committee. Yasmin E; Davies M; Conway G; Balen AH; British Fertility Society Hum Fertil (Camb); 2013 Dec; 16(4):228-34. PubMed ID: 24245485 [No Abstract] [Full Text] [Related]
27. Treatment with pulsatile luteinizing hormone-releasing hormone modulates folliculogenesis in response to ovarian stimulation with exogenous gonadotropins in patients with polycystic ovaries. Homburg R; Kilborn J; West C; Jacobs HS Fertil Steril; 1990 Oct; 54(4):737-9. PubMed ID: 2120089 [TBL] [Abstract][Full Text] [Related]
28. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. Barnes RB J Endocrinol Invest; 1998 Oct; 21(9):567-79. PubMed ID: 9856411 [TBL] [Abstract][Full Text] [Related]
29. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730 [TBL] [Abstract][Full Text] [Related]
30. The evaluation and treatment of androgen excess. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S241-7. PubMed ID: 17055833 [No Abstract] [Full Text] [Related]
31. Hormonal therapy in ovarian cancer. Zheng H; Kavanagh JJ; Hu W; Liao Q; Fu S Int J Gynecol Cancer; 2007; 17(2):325-38. PubMed ID: 17362310 [TBL] [Abstract][Full Text] [Related]
32. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment. Cheung AP; Lu JK; Chang RJ Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993 [TBL] [Abstract][Full Text] [Related]
33. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease. Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650 [TBL] [Abstract][Full Text] [Related]